Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.04 AUD | -1.95% | -0.28% | -8.33% |
Mar. 25 | Miners, healthcare firms push Australia stocks higher | RE |
Mar. 19 | Australia shares flat ahead of key RBA policy decision | RE |
Summary
- The company has a good ESG score relative to its sector, according to Refinitiv.
Strengths
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- The group's activity appears highly profitable thanks to its outperforming net margins.
- The company appears to be poorly valued given its net asset value.
- This company will be of major interest to investors in search of a high dividend stock.
- The group usually releases upbeat results with huge surprise rates.
Weaknesses
- With relatively low growth outlooks, the group is not among those with the highest revenue growth potential.
- The company's currently anticipated earnings per share (EPS) growth for the next few years is a notable weakness.
- The company is in a hindered financial situation with significant debt and rather low EBITDA levels.
- The company's "enterprise value to sales" ratio is among the highest in the world.
- The company is highly valued given the cash flows generated by its activity.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
- The average consensus view of analysts covering the stock has deteriorated over the past four months.
- Over the past twelve months, analysts' consensus has been significantly revised downwards.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Commercial REITs
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-8.33% | 4.93B | A+ | ||
-12.34% | 9.66B | A- | ||
-1.80% | 6.48B | C | ||
-8.05% | 4.85B | B- | ||
+11.51% | 4.11B | B | ||
-4.73% | 4.02B | - | ||
-16.82% | 3.89B | A- | ||
+12.04% | 3.28B | B+ | ||
-15.11% | 3.16B | B | ||
-1.19% | 3.03B | B |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- DXS Stock
- Ratings DEXUS